World's Best Scientists 2026 revealed!

D-Index & Metrics

Neuroscience

D-Index
54
Citations
12437
World Ranking
4878
National Ranking
2198

Overview

Gregory J. Moore is affiliated with Stanford University School of Medicine in the United States. Their research spans multiple areas within medicine, with a notable focus on molecular biology, radiology, nuclear medicine and imaging, physiology, oncology, and pathology and forensic medicine.

The scientist's main topics of work involve advanced MRI techniques and applications, biochemical effects in animals, DNA repair mechanisms, CRISPR and genetic engineering, PARP inhibition in cancer therapy, spine and intervertebral disc pathology, as well as musculoskeletal pain and rehabilitation.

Recent published papers by Gregory J. Moore include the following:

  • Magnetic Resonance Spectroscopy: Neurochemistry and Treatment Effects in Affective Disorders, 2025, Psychopharmacology Bulletin
  • Artificial intelligence and the acceleration of Alzheimer's research - From promise to practice, 2025, The Journal of Prevention of Alzheimer s Disease

Frequent coauthors who have collaborated with Moore include:

  • Matthew P. Galloway
  • Husseini K. Manji
  • Joshua L. Turner
  • Tyler J. McCraw
  • Jennifer M. Mason

Key publication venues for Moore's work are:

  • Psychopharmacology Bulletin
  • The Journal of Prevention of Alzheimer s Disease
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Brain and Spine

Best Publications

  • Neural substrates for voluntary suppression of negative affect: a functional magnetic resonance imaging study.

    K. Luan Phan;Daniel A. Fitzgerald;Pradeep J. Nathan;Gregory J. Moore

  • Lithium-induced increase in human brain grey matter

    Gregory J Moore;Joseph M Bebchuk;Ian B Wilds;Guang Chen

  • Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?

    Gregory J Moore;Joseph M Bebchuk;Khondakar Hasanat;Guang Chen

  • Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine.

    David R. Rosenberg;Frank P. MacMASTER;Matcheri S. Keshavan;Kate D. Fitzgerald

  • Neuroplasticity and cellular resilience in mood disorders.

    H K Manji;G J Moore;G Rajkowska;G Chen

  • Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic–depressive illness

    Husseini K Manji;Gregory J Moore;Guang Chen

  • Advanced machine learning in action: identification of intracranial hemorrhage on computed tomography scans of the head with clinical workflow integration.

    Mohammad R. Arbabshirani;Brandon K. Fornwalt;Gino J. Mongelluzzo;Jonathan D. Suever

  • Lithium at 50: have the neuroprotective effects of this unique cation been overlooked?

    Husseini K Manji;Gregory J Moore;Guang Chen

  • Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine.

    Andrew R. Gilbert;Gregory J. Moore;Matcheri S. Keshavan;Lori Anne D. Paulson

  • Lithium up-regulates the cytoprotective protein Bcl-2 in the CNS in vivo: a role for neurotrophic and neuroprotective effects in manic depressive illness.

    Husseini K. Manji;Gregory J. Moore;Guang Chen

  • Real-time fMRI of temporolimbic regions detects amygdala activation during single-trial self-induced sadness

    Stefan Posse;Daniel Fitzgerald;Kunxiu Gao;Ute Habel

  • Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation.

    James Y. Garbern;Donald A. Yool;Gregory J. Moore;Ian B. Wilds

  • Reduced anterior cingulate glutamatergic concentrations in childhood OCD and major depression versus healthy controls

    David R. Rosenberg;Yousha Mirza;Aileen Russell;Jennifer Tang

  • Prefrontal cortex as the site of estrogen's effect on cognition.

    P.A Keenan;W.H Ezzat;K Ginsburg;G.J Moore

  • Temporal Dissociation Between Lithium-Induced Changes in Frontal Lobe myo-Inositol and Clinical Response in Manic-Depressive Illness

    Gregory J. Moore;Joseph M. Bebchuk;Julieclaire K. Parrish;Michael W. Faulk

  • Brain Structural Abnormalities in Psychotropic Drug-Naive Pediatric Patients With Obsessive-Compulsive Disorder

    Philip R. Szeszko;Shauna MacMillan;Marjorie McMeniman;Steven Chen

  • Evidence of altered energy metabolism in autistic children.

    Diane C. Chugani;Bhavani S. Sundram;Michael Behen;Mei-Li Lee

  • Amygdala and hippocampal volumes in familial early onset major depressive disorder.

    Frank P. MacMaster;Yousha Mirza;Philip R. Szeszko;Lauren E. Kmiecik

  • A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients.

    Gregory J. Moore;Bernadette M. Cortese;Debra A. Glitz;Caroline Zajac-Benitez

  • Increased amygdala: hippocampal volume ratios associated with severity of anxiety in pediatric major depression.

    Shauna MacMillan;Philip R. Szeszko;Gregory J. Moore;Rachel Madden

Frequent Co-Authors

David R. Rosenberg
David R. Rosenberg Wayne State University
Stefan Posse
Stefan Posse University of New Mexico
Daniel A. Fitzgerald
Daniel A. Fitzgerald University of Illinois at Chicago
Philip R. Szeszko
Philip R. Szeszko Icahn School of Medicine at Mount Sinai
K. Luan Phan
K. Luan Phan The Ohio State University
Stefi A. Baum
Stefi A. Baum University of Manitoba
Kate D. Fitzgerald
Kate D. Fitzgerald Columbia University
Harry T. Chugani
Harry T. Chugani New York University
Stephen R. Dager
Stephen R. Dager University of Washington
Pradeep J. Nathan
Pradeep J. Nathan University of Cambridge

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Gregory J. Moore

Trending Scientists

Recently Published Articles